| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.545 | |
| mrna processing | GO:0006397 | 63 | 0.373 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.371 | |
| rna splicing | GO:0008380 | 54 | 0.359 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.356 | |
| stem cell maintenance | GO:0019827 | 130 | 0.237 | |
| rna processing | GO:0006396 | 105 | 0.176 | |
| male gamete generation | GO:0048232 | 285 | 0.143 | |
| nuclear division | GO:0000280 | 158 | 0.134 | |
| spermatid differentiation | GO:0048515 | 115 | 0.132 | |
| spermatid development | GO:0007286 | 108 | 0.132 | |
| mrna metabolic process | GO:0016071 | 84 | 0.131 | |
| germ cell development | GO:0007281 | 185 | 0.129 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.114 | |
| nuclear transcribed mrna catabolic process nonsense mediated decay | GO:0000184 | 1 | 0.101 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.097 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.094 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.090 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.088 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.085 | |
| dna metabolic process | GO:0006259 | 303 | 0.083 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.075 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.074 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.067 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.066 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.065 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.063 | |
| regionalization | GO:0003002 | 337 | 0.062 | Mouse |
| gonad development | GO:0008406 | 141 | 0.057 | |
| circadian rhythm | GO:0007623 | 114 | 0.055 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.055 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.054 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.052 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.052 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.050 | |
| spermatogenesis | GO:0007283 | 284 | 0.050 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.050 | |
| intracellular protein transport | GO:0006886 | 204 | 0.050 | |
| microtubule based process | GO:0007017 | 236 | 0.049 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.047 | |
| amine metabolic process | GO:0009308 | 45 | 0.046 | |
| protein refolding | GO:0042026 | 1 | 0.046 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.045 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.045 | |
| stem cell development | GO:0048864 | 219 | 0.044 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.043 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.043 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.040 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.040 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.040 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.040 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.039 | |
| ossification | GO:0001503 | 216 | 0.039 | |
| stem cell differentiation | GO:0048863 | 268 | 0.039 | |
| organelle fission | GO:0048285 | 170 | 0.038 | |
| defense response to other organism | GO:0098542 | 197 | 0.037 | |
| translation | GO:0006412 | 93 | 0.037 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.037 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.037 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.036 | |
| rna catabolic process | GO:0006401 | 29 | 0.036 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 4 | 0.036 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.035 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.034 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.034 | |
| 3 utr mediated mrna stabilization | GO:0070935 | 2 | 0.034 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.033 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.032 | |
| membrane organization | GO:0061024 | 245 | 0.032 | |
| cytokine production | GO:0001816 | 319 | 0.031 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.031 | |
| cell division | GO:0051301 | 120 | 0.031 | |
| female sex differentiation | GO:0046660 | 84 | 0.030 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.029 | |
| response to heat | GO:0009408 | 27 | 0.029 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.029 | |
| rhythmic process | GO:0048511 | 174 | 0.029 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.028 | |
| glucose homeostasis | GO:0042593 | 128 | 0.027 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.027 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.026 | |
| mrna catabolic process | GO:0006402 | 22 | 0.026 | |
| male anatomical structure morphogenesis | GO:0090598 | 4 | 0.026 | |
| response to nutrient levels | GO:0031667 | 109 | 0.026 | |
| adult behavior | GO:0030534 | 135 | 0.025 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.024 | |
| maintenance of location | GO:0051235 | 89 | 0.024 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.024 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.023 | |
| chromatin organization | GO:0006325 | 206 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | Worm |
| macromolecule methylation | GO:0043414 | 120 | 0.022 | |
| forebrain development | GO:0030900 | 302 | 0.022 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.022 | |
| skin development | GO:0043588 | 220 | 0.021 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.021 | |
| protein localization to membrane | GO:0072657 | 108 | 0.020 | |
| dna recombination | GO:0006310 | 92 | 0.020 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.020 | |
| inflammatory response | GO:0006954 | 244 | 0.020 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.019 | |
| blastocyst development | GO:0001824 | 80 | 0.019 | |
| cellular response to lipid | GO:0071396 | 145 | 0.019 | |
| rna interference | GO:0016246 | 2 | 0.019 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.019 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.019 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.018 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.018 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.018 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.018 | |
| regulation of ossification | GO:0030278 | 112 | 0.017 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.017 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.017 | |
| muscle tissue development | GO:0060537 | 308 | 0.017 | |
| intraciliary transport | GO:0042073 | 9 | 0.017 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.017 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.017 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.017 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.017 | |
| digestive tract development | GO:0048565 | 190 | 0.017 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.017 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.016 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.016 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.016 | |
| histone acetylation | GO:0016573 | 41 | 0.016 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.016 | |
| centrosome organization | GO:0051297 | 26 | 0.016 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.016 | |
| immune effector process | GO:0002252 | 321 | 0.015 | |
| protein acylation | GO:0043543 | 64 | 0.015 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.015 | |
| response to radiation | GO:0009314 | 165 | 0.015 | |
| gland development | GO:0048732 | 330 | 0.015 | |
| protein glycosylation | GO:0006486 | 55 | 0.015 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.015 | |
| protein localization to organelle | GO:0033365 | 185 | 0.015 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.015 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.015 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.014 | |
| response to starvation | GO:0042594 | 65 | 0.014 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.014 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.014 | |
| muscle contraction | GO:0006936 | 101 | 0.014 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.014 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.014 | |
| oogenesis | GO:0048477 | 56 | 0.014 | |
| organelle localization | GO:0051640 | 179 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.014 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.013 | |
| oocyte construction | GO:0007308 | 2 | 0.013 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| histone modification | GO:0016570 | 159 | 0.013 | |
| ear development | GO:0043583 | 200 | 0.013 | |
| gene silencing by rna | GO:0031047 | 19 | 0.013 | |
| histone methylation | GO:0016571 | 71 | 0.013 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.012 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.012 | |
| translesion synthesis | GO:0019985 | 1 | 0.012 | |
| negative regulation of mrna splicing via spliceosome | GO:0048025 | 12 | 0.012 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.012 | |
| regulation of rna stability | GO:0043487 | 26 | 0.012 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.012 | |
| response to peptide | GO:1901652 | 136 | 0.012 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.012 | |
| sensory perception | GO:0007600 | 245 | 0.012 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.012 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.012 | |
| primary mirna processing | GO:0031053 | 1 | 0.012 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.012 | |
| regulation of protein transport | GO:0051223 | 163 | 0.012 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.012 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.011 | |
| humoral immune response | GO:0006959 | 57 | 0.011 | |
| regulation of defense response | GO:0031347 | 233 | 0.011 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.011 | |
| neuronal action potential | GO:0019228 | 54 | 0.011 | |
| cell junction organization | GO:0034330 | 77 | 0.011 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.011 | |
| oocyte axis specification | GO:0007309 | 2 | 0.011 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.011 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.011 | |
| urogenital system development | GO:0001655 | 261 | 0.011 | |
| regulation of translation | GO:0006417 | 71 | 0.011 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.011 | |
| dendrite development | GO:0016358 | 115 | 0.011 | |
| response to acid chemical | GO:0001101 | 111 | 0.011 | |
| positive regulation of nuclear division | GO:0051785 | 27 | 0.011 | |
| response to drug | GO:0042493 | 75 | 0.011 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.011 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.011 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.011 | |
| regulation of protein localization | GO:0032880 | 231 | 0.011 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.011 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.011 | |
| spliceosomal complex assembly | GO:0000245 | 6 | 0.011 | |
| lipid localization | GO:0010876 | 126 | 0.011 | |
| microtubule based transport | GO:0010970 | 50 | 0.011 | |
| dna repair | GO:0006281 | 107 | 0.010 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.010 | |
| synaptic transmission | GO:0007268 | 329 | 0.010 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.010 | |
| response to catecholamine | GO:0071869 | 4 | 0.010 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.010 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.010 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.010 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.010 | |
| gastrulation | GO:0007369 | 116 | 0.010 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.010 | |
| cellularization | GO:0007349 | 1 | 0.010 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.010 | |
| methylation | GO:0032259 | 134 | 0.010 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.010 | |
